Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[Buddhahead]

NF-kappaB as a therapeutic target in chronic inflammation: recent advances in Research Gate, S S Makarov, Thurston Arthritis Research Center, Center for Inflammatory Disorders, and Department of Endodontics, University of North Carolina at Chapel Hill, 27599-7280, USA., Source: PubMed, no date

ABSTRACT:
" The family of nuclear factor kappaB (NF-kappaB) transcription factors is a topic of intense interest in the biomedical community stemming from the role NF-kappaB plays in almost every aspect of cell regulation: stress responses, immune cell activation, apoptosis, proliferation, differentiation and oncogenic transformation. The objective of this article is to provide an overview of recent developments in the field with an emphasis on the role of NF-kappaB in chronic inflammation, and to discuss the feasibility of therapeutic approaches based on the specific suppression of the NF-kappaB pathway."

Article at:
http://www.researchgate.net/publication/12254037_NF-kappaB_as_a_therapeutic_target_in_chronic_inflammation_recent_advances